IonQ announced a new partnership with CCRM on Dec 1 to use quantum computing for medical research. Projects are set to start next year in Canada and Sweden. This follows their Q3 earnings report where revenue came in at $39.9 million, up 222% year-over-year and beating expectations. Management raised full-year 2025 revenue guidance to between $106 million and $110 million. The company is still operating at a loss with an adjusted EPS of -$0.17, but they reported $3.5 billion in cash and investments after a recent equity raise. They also hit a technical milestone of 99.99% two-qubit gate fidelity. Cantor Fitzgerald recently raised their price target on the stock to $70.